|
Volumn 96, Issue SUPPL. 2, 2002, Pages 1-23
|
National guideline for the care of diabetes mellitus type 2;National versorgungs-leitlinie: Diabetes mellitus typ 2
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ACARBOSE;
ALPHA GLUCOSIDASE INHIBITOR;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHOLESTEROL;
CREATININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOLYTIC AGENT;
GLIBENCLAMIDE;
GLIBORNURIDE;
GLICLAZIDE;
GLIMEPIRIDE;
GLIQUIDONE;
GLUCOSE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
ISOPHANE INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METFORMIN;
MIGLITOL;
NATEGLINIDE;
ORAL ANTIDIABETIC AGENT;
PIOGLITAZONE;
REPAGLINIDE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
UNINDEXED DRUG;
BODY MASS;
CARDIOSELECTIVITY;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
ENZYME INHIBITION;
EVIDENCE BASED MEDICINE;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL GLUCOSE TOLERANCE TEST;
PRACTICE GUIDELINE;
RETINA MACULOPATHY;
SHORT SURVEY;
SYMPTOMATOLOGY;
|
EID: 0036345379
PISSN: 14317621
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (0)
|